Samsung Bioepis, a subsidiary of Samsung Epis Holdings, achieved its highest annual sales performance last year. According to ...
Amgen Inc. Buy thesis: strong pipeline, 12% Q3 2025 revenue growth and MariTide obesity upside. Click for this updated look ...
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...
The US biosimilar market evolves with 90 approvals, significant price drops, and new PBM models enhancing access to ...
The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...